BA vs LMT vs GD
161 measures in 16 categories, one definition each, computed from filings and market data.
LMT68.4
Lockheed Martin Corporation
Industrials · Aerospace & Defense
$552.09 +3.62%$127.4B mkt cap
Score DNA
GD66.1
General Dynamics Corporation
Industrials · Aerospace & Defense
$344.23 +2.12%$93.1B mkt cap
Score DNA
Price, rebased to 100 three years ago
BA LMT GD · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Insider open-market buys, 180d | 1 | 0 | 0 |
| Insider $ bought, 180d | $0.30M | — | — |
| Congress purchases, 180d | 0 | 1 | 0 |
| Last Congress purchase | — | 2026-03-27 | — |
| 13F net change in holders | +108 | −141 | −2 |
| ETFs adding shares, 30d | 956 | 992 | 962 |
| ETFs trimming, 30d | 704 | 756 | 710 |
| Net ETF funds, 30d | +252 | +236 | +252 |
Valuation
16 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| P/E (TTM) | 61.7x
87th
|
20.3x
8th
|
20.8x
15th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | 2.03
67th
|
| Price / sales | 1.6x
16th
|
1.7x
20th
|
1.7x
22nd
|
| Price / book | 24.6x
96th
|
14.5x
87th
|
3.5x
47th
|
| Price / tangible book | — | — | 22.1x
68th
|
| Price / free cash flow | — | 14.6x
17th
|
14.4x
11th
|
| Price / operating cash flow | 41.3x
82nd
|
12.2x
15th
|
12.1x
13th
|
| Enterprise value | $176.2B
96th
|
$144.2B
95th
|
$98.3B
93rd
|
| EV / sales | 1.9x
20th
|
1.9x
18th
|
1.8x
16th
|
| EV / EBITDA | 23.4x
64th
|
14.1x
26th
|
15.3x
29th
|
| EV / EBIT | 32.9x
69th
|
16.8x
21st
|
17.1x
23rd
|
| EV / free cash flow | — | 16.5x
14th
|
15.2x
11th
|
| Earnings yield | 1.6%
38th
|
4.9%
95th
|
4.8%
89th
|
| FCF yield | -0.1%
31st
|
6.9%
89th
|
6.9%
93rd
|
| Operating cash flow yield | 2.4%
42nd
|
8.2%
89th
|
8.3%
91st
|
| Graham number (per share) | $23.11
39th
|
$152.39
84th
|
$190.07
95th
|
Profitability (TTM)
12 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Gross margin | 4.7%
2nd
|
11.8%
11th
|
15.4%
19th
|
| EBITDA margin | 8.0%
34th
|
13.3%
58th
|
11.7%
45th
|
| Operating margin | -5.4%
19th
|
11.9%
75th
|
10.3%
58th
|
| EBIT margin | 5.7%
34th
|
11.1%
60th
|
10.5%
57th
|
| Net margin | 2.6%
34th
|
8.2%
60th
|
8.2%
64th
|
| NOPAT margin | -5.0%
19th
|
10.1%
72nd
|
8.5%
62nd
|
| FCF margin | -0.2%
28th
|
11.3%
74th
|
11.8%
77th
|
| Operating cash flow margin | 3.9%
38th
|
13.5%
70th
|
14.0%
74th
|
| R&D / revenue | 3.9%
71st
|
0.9%
40th
|
0.9%
42nd
|
| SG&A / revenue | 6.2%
19th
|
0.0%
0th
|
5.0%
17th
|
| Stock comp / revenue | 0.4%
19th
|
0.4%
24th
|
0.4%
20th
|
| Effective tax rate | 7.5%
4th
|
15.3%
20th
|
17.6%
35th
|
Returns on capital
11 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| ROE (on average equity) | 173.6%
96th
|
89.2%
94th
|
17.8%
71st
|
| ROA | 1.5%
31st
|
10.4%
91st
|
7.7%
67th
|
| ROIC | -14.7%
16th
|
30.4%
96th
|
14.6%
76th
|
| ROCE | 9.5%
56th
|
22.2%
98th
|
13.9%
76th
|
| Return on tangible assets | 3.3%
35th
|
14.1%
91st
|
9.8%
67th
|
| Cash ROIC (OCF / invested capital) | 11.4%
59th
|
40.8%
96th
|
24.1%
87th
|
| Gross profitability (GP / assets) | 2.7%
9th
|
14.5%
49th
|
14.0%
45th
|
| ROIC, 3-yr average | -20.0%
3rd
|
28.3%
100th
|
11.5%
82nd
|
| ROIC, 5-yr average | — | 31.7%
98th
|
12.3%
71st
|
| ROE, 5-yr average | — | 75.4%
98th
|
17.3%
85th
|
| Incremental ROIC | 264.2%
96th
|
179.6%
92nd
|
61.7%
70th
|
Growth
17 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Revenue growth (TTM YoY) | 24.8%
63rd
|
7.2%
10th
|
9.1%
20th
|
| Revenue growth (QoQ) | 10.5%
55th
|
11.3%
56th
|
4.5%
27th
|
| Revenue CAGR, 3 yr | 8.5%
28th
|
4.6%
15th
|
10.3%
37th
|
| Revenue CAGR, 5 yr | 8.8%
40th
|
2.9%
12th
|
7.3%
26th
|
| Gross profit CAGR, 3 yr | -3.2%
7th
|
2.0%
14th
|
8.6%
31st
|
| Operating income CAGR, 3 yr | — | 2.0%
18th
|
10.3%
29th
|
| Net income growth (TTM YoY) | — | 49.5%
58th
|
9.8%
17th
|
| Net income CAGR, 3 yr | — | -3.8%
10th
|
10.0%
33rd
|
| EPS growth (TTM YoY) | — | 51.6%
64th
|
8.7%
17th
|
| EPS CAGR, 3 yr | — | -0.8%
17th
|
10.2%
37th
|
| EPS CAGR, 5 yr | — | 1.2%
23rd
|
7.1%
38th
|
| FCF growth (TTM YoY) | — | 162.2%
81st
|
56.1%
65th
|
| FCF CAGR, 3 yr | — | 13.3%
27th
|
28.7%
64th
|
| Operating cash flow CAGR, 3 yr | -26.6%
0th
|
10.4%
24th
|
23.0%
52nd
|
| Book value CAGR, 3 yr | — | 1.4%
30th
|
11.4%
59th
|
| Dividend CAGR, 3 yr | 18.7%
97th
|
4.0%
62nd
|
1.8%
34th
|
| Sustainable growth rate | 149.0%
100th
|
44.1%
92nd
|
11.3%
47th
|
Margin history & stability
7 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Gross margin, 3-yr average | 4.6%
0th
|
10.7%
7th
|
15.5%
17th
|
| Operating margin, 3-yr average | -6.7%
15th
|
10.7%
67th
|
10.2%
63rd
|
| Net margin, 3-yr average | -5.4%
15th
|
7.8%
63rd
|
8.1%
65th
|
| FCF margin, 3-yr average | -6.4%
20th
|
8.6%
67th
|
8.3%
65th
|
| Revenue stability (0-1) | 0.81
29th
|
0.84
38th
|
0.92
56th
|
| Earnings stability (0-1) | 0.23
19th
|
0.07
4th
|
0.85
81st
|
| Margin stability (0-1) | 0.33
13th
|
0.83
38th
|
0.96
81st
|
Liquidity (latest quarter)
7 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Cash & short-term investments | $20.0B
100th
|
$3.8B
93rd
|
$4.3B
95th
|
| Net cash (− = net debt) | −$25.9B
4th
|
−$16.7B
5th
|
−$5.1B
13th
|
| Working capital | $15.1B
100th
|
$4.6B
95th
|
$8.3B
98th
|
| Current ratio | 1.14
5th
|
1.19
11th
|
1.44
18th
|
| Quick ratio | 0.33
0th
|
1.01
18th
|
0.96
13th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.18
20th
|
0.16
13th
|
0.23
31st
|
| Defensive interval (days) | 1,280 days
74th
|
— | 2,105 days
87th
|
Leverage & solvency (latest quarter)
13 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Total debt | $45.9B
100th
|
$20.5B
95th
|
$9.5B
87th
|
| Debt / equity | 7.52
96th
|
2.34
91st
|
0.35
36th
|
| Net debt / equity | 4.24
96th
|
1.91
92nd
|
0.19
42nd
|
| Debt / assets | 27.7%
62nd
|
32.9%
71st
|
15.8%
33rd
|
| Debt / capital | 88.3%
96th
|
70.1%
91st
|
26.1%
36th
|
| Debt / EBITDA | 6.08
93rd
|
2.00
43rd
|
1.47
21st
|
| Net debt / EBITDA | 3.43
81st
|
1.63
43rd
|
0.80
29th
|
| Interest coverage (EBIT / interest) | 2.1x
25th
|
7.7x
65th
|
22.5x
94th
|
| Cash interest coverage | 1.4x
29th
|
9.4x
73rd
|
30.2x
96th
|
| Debt payback (years of OCF) | 12.6 yrs
90th
|
2.0 yrs
28th
|
1.2 yrs
21st
|
| Liabilities / assets | 96.3%
96th
|
86.0%
89th
|
55.4%
56th
|
| IS credit model rating | B- | A | AA+ |
| Implied credit spread (bps) | 900
93rd
|
150
35th
|
65
5th
|
Efficiency
11 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Asset turnover | 0.59
49th
|
1.27
95th
|
0.94
78th
|
| Fixed asset turnover | 5.76
57th
|
6.76
70th
|
7.24
74th
|
| Inventory turnover | 1.0
0th
|
16.8
82nd
|
4.9
60th
|
| Receivables turnover | 28.0
100th
|
7.1
61st
|
18.3
98th
|
| Days sales outstanding | 13 days
2nd
|
51 days
40th
|
20 days
4th
|
| Days inventory outstanding | 359 days
100th
|
22 days
18th
|
75 days
40th
|
| Days payables outstanding | 52 days
71st
|
23 days
2nd
|
23 days
9th
|
| Cash conversion cycle (days) | 320 days
98th
|
50 days
33rd
|
71 days
38th
|
| Capex / revenue | 4.1%
58th
|
2.2%
23rd
|
2.3%
26th
|
| Capex / depreciation | 1.75
72nd
|
0.99
43rd
|
1.80
74th
|
| Operating expense ratio | 9.5%
23rd
|
— | 5.1%
2nd
|
Cash flow & earnings quality
7 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Operating cash flow / net income | 1.49
64th
|
1.65
74th
|
1.72
79th
|
| FCF / net income | −0.09
13th
|
1.39
74th
|
1.44
79th
|
| FCF / operating cash flow | -5.8%
3rd
|
83.9%
68th
|
83.7%
66th
|
| Capex / operating cash flow | 105.8%
97th
|
16.1%
32nd
|
16.3%
34th
|
| Accruals ratio | -0.8%
64th
|
-6.8%
16th
|
-5.5%
25th
|
| Sloan accruals ratio | -6.9%
18th
|
5.4%
69th
|
1.5%
64th
|
| Earnings quality score (0-1) | 1.00
49th
|
0.75
23rd
|
0.75
23rd
|
Scores & forensic checks
15 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| IS score | 43
33rd
|
68
84th
|
66
80th
|
| IS profitability | 25
42nd
|
49
73rd
|
39
64th
|
| IS growth | 97
100th
|
72
59th
|
54
24th
|
| IS value | 32
15th
|
46
62nd
|
52
85th
|
| IS momentum | 100
96th
|
89
69th
|
81
53rd
|
| IS risk (safety) | 30
7th
|
80
29th
|
100
44th
|
| IS quality | 45
27th
|
67
56th
|
77
91st
|
| IS balance sheet | 34
18th
|
42
29th
|
71
75th
|
| IS earnings quality | 84
100th
|
82
95th
|
68
55th
|
| IS cash flow | 35
40th
|
71
82nd
|
75
93rd
|
| Piotroski F-score (0-9) | 6
31st
|
9
100th
|
8
84th
|
| Altman Z-score | 1.6
9th
|
3.4
35th
|
4.3
45th
|
| Beneish M-score | −2.16
72nd
|
−3.70
4th
|
−2.78
22nd
|
| Ohlson O-score | −6.69
73rd
|
−6.99
65th
|
−8.85
22nd
|
| IS credit score | 22
4th
|
74
65th
|
92
89th
|
Size (TTM)
8 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| Market cap | $150.3B
96th
|
$127.4B
95th
|
$93.1B
93rd
|
| Revenue | $94.0B
100th
|
$77.0B
96th
|
$54.9B
95th
|
| EBITDA | $7.5B
95th
|
$10.3B
96th
|
$6.4B
91st
|
| Net income | $2.4B
91st
|
$6.3B
96th
|
$4.5B
93rd
|
| Free cash flow | −$210.0M
16th
|
$8.7B
98th
|
$6.4B
95th
|
| Total assets | $165.9B
98th
|
$62.5B
95th
|
$60.2B
93rd
|
| Shareholders' equity | $6.1B
87th
|
$8.8B
91st
|
$26.8B
98th
|
| Employees | 182,000
100th
|
123,000
96th
|
117,000
95th
|
Price performance
9 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| 1 day | +0.7% | +3.6% | +2.1% |
| 1 week | −0.2% | +8.3% | +3.9% |
| 1 month | −3.5% | +2.6% | −3.3% |
| 3 months | −9.3% | +8.3% | −7.1% |
| 6 months | −14.9% | −6.8% | +2.4% |
| Year to date | −16.6% | +11.6% | +0.6% |
| 1 year | −11.2% | +11.4% | +3.7% |
| 3 years, cumulative | −3.1% | +34.5% | +50.7% |
| 5 years, cumulative | −16.1% | +75.2% | +85.5% |
Technicals
4 measures| Measure | BA | LMT | GD |
|---|---|---|---|
| RSI 14 | 43.3 | 64.8 | 53.1 |
| From 52-week high | −25.3% | −20.2% | −13.9% |
| From 52-week low | +7.5% | +26.2% | +12.2% |
| Beta | 1.26 | 0.10 | 0.33 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17